$EDIT 8-K SEC Filings

Filed On	Filing
08 Oct 2026	8-K: Regulation FD Disclosure; Other Events Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering
05 Aug 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
26 May 2026	8-K: Entry into a Material Definitive Agreement; Other Events
26 May 2026	8-K: Other Events
26 May 2026	8-K: Regulation FD Disclosure; Other Events
14 May 2026	8-K: Regulation FD Disclosure; Other Events
05 May 2026	8-K: Results of Operations and Financial Condition
07 Apr 2026	8-K: Changes in Registrant's Certifying Accountant
27 Mar 2026	8-K: Regulation FD Disclosure; Other Events
09 Mar 2026	8-K: Results of Operations and Financial Condition
10 Nov 2025	8-K: Results of Operations and Financial Condition
09 Oct 2025	8-K: Regulation FD Disclosure; Other Events
02 Sep 2025	8-K: Regulation FD Disclosure; Other Events
12 Aug 2025	8-K: Results of Operations and Financial Condition
12 Jun 2025	8-K: Regulation FD Disclosure; Other Events
02 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
14 May 2025	8-K: Regulation FD Disclosure; Other Events
13 May 2025	8-K: Regulation FD Disclosure; Other Events
12 May 2025	8-K: Results of Operations and Financial Condition

Comments